# Early Use of Botulinum Toxin in Spasticity Post Stroke.

> **NCT01882556** · PHASE2 · COMPLETED · sponsor: **Sandwell & West Birmingham Hospitals NHS Trust** · enrollment: 120 (actual)

## Conditions studied

- Stroke
- Muscle Spasticity
- Contracture

## Interventions

- **DRUG:** onabotulinumtoxinA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01882556
- **Lead sponsor:** Sandwell & West Birmingham Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-11-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01882556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01882556, "Early Use of Botulinum Toxin in Spasticity Post Stroke.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01882556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*